Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991-2008
- PMID: 21505134
- PMCID: PMC3108186
- DOI: 10.1001/jama.2011.478
Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991-2008
Abstract
Context: Total hip arthroplasty is a common surgical procedure but little is known about longitudinal trends.
Objective: To examine demographics and outcomes of patients undergoing primary and revision total hip arthroplasty.
Design, setting, and participants: Observational cohort of 1,453,493 Medicare Part A beneficiaries who underwent primary total hip arthroplasty and 348,596 who underwent revision total hip arthroplasty. Participants were identified using International Classification of Diseases, Ninth Revision, Clinical Modification codes for primary and revision total hip arthroplasty between 1991 and 2008.
Main outcome measures: Changes in patient demographics and comorbidity, hospital length of stay (LOS), mortality, discharge disposition, and all-cause readmission rates.
Results: Between 1991 and 2008, the mean age for patients undergoing primary total hip arthroplasty increased from 74.1 to 75.1 years and for revision total hip arthroplasty from 75.8 to 77.3 years (P < .001). The mean number of comorbid illnesses per patient increased from 1.0 to 2.0 for primary total hip arthroplasty and 1.1 to 2.3 for revision (P < .001). For primary total hip arthroplasty, mean hospital LOS decreased from 9.1 days in 1991-1992 to 3.7 days in 2007-2008 (P = .002); unadjusted in-hospital and 30-day mortality decreased from 0.5% to 0.2% and from 0.7% to 0.4%, respectively (P < .001). The proportion of primary total hip arthroplasty patients discharged home declined from 68.0% to 48.2%; the proportion discharged to skilled care increased from 17.8% to 34.3%; and 30-day all-cause readmission increased from 5.9% to 8.5% (P < .001). For revision total hip arthroplasty, similar trends were observed in hospital LOS, in-hospital mortality, discharge disposition, and hospital readmission rates.
Conclusion: Among Medicare beneficiaries who underwent primary and revision hip arthroplasty between 1991 and 2008, there was a decrease in hospital LOS but an increase in the rates of discharge to postacute care and readmission.
Conflict of interest statement
None of the authors have any conflicts of interest.
Comment in
-
Readmission rates after total hip arthroplasty.JAMA. 2011 Aug 24;306(8):825; author reply 825-6. doi: 10.1001/jama.2011.1182. JAMA. 2011. PMID: 21862739 No abstract available.
Similar articles
-
Adverse outcomes in hip arthroplasty: long-term trends.J Bone Joint Surg Am. 2012 Jul 18;94(14):e103. doi: 10.2106/JBJS.K.00011. J Bone Joint Surg Am. 2012. PMID: 22810410 Free PMC article.
-
Hospital Readmission and Length of Stay Over Time in Patients Undergoing Major Cardiovascular and Orthopedic Surgery: A Tale of 2 States.Med Care. 2016 Jun;54(6):592-9. doi: 10.1097/MLR.0000000000000528. Med Care. 2016. PMID: 26974680
-
Post-Discharge Care Duration, Charges, and Outcomes Among Medicare Patients After Primary Total Hip and Knee Arthroplasty.J Bone Joint Surg Am. 2017 Jun 7;99(11):e55. doi: 10.2106/JBJS.16.00166. J Bone Joint Surg Am. 2017. PMID: 28590385
-
Factors associated with hospital stay length, discharge destination, and 30-day readmission rate after primary hip or knee arthroplasty: Retrospective Cohort Study.Orthop Traumatol Surg Res. 2019 Sep;105(5):949-955. doi: 10.1016/j.otsr.2019.04.012. Epub 2019 Jun 15. Orthop Traumatol Surg Res. 2019. PMID: 31208932 Review.
-
The Validity of All-Cause 30-Day Readmission Rate as a Hospital Performance Metric After Primary Total Hip and Knee Arthroplasty: A Systematic Review.J Arthroplasty. 2019 Aug;34(8):1831-1836. doi: 10.1016/j.arth.2019.04.011. Epub 2019 Apr 13. J Arthroplasty. 2019. PMID: 31072744
Cited by
-
Impact of Medicare's Nonpayment Program on Venous Thromboembolism Following Hip and Knee Replacements.Health Serv Res. 2018 Dec;53(6):4381-4402. doi: 10.1111/1475-6773.13013. Epub 2018 Jul 18. Health Serv Res. 2018. PMID: 30022482 Free PMC article.
-
Long-Term Mortality Trends After Total Hip and Knee Arthroplasties: A Population-Based Study.J Arthroplasty. 2016 Jun;31(6):1163-1169. doi: 10.1016/j.arth.2015.12.010. Epub 2015 Dec 17. J Arthroplasty. 2016. PMID: 26777550 Free PMC article.
-
Application and evaluation of artificial intelligence 3D preoperative planning software in developmental dysplasia of the hip.J Orthop Surg Res. 2024 Mar 8;19(1):176. doi: 10.1186/s13018-024-04588-0. J Orthop Surg Res. 2024. PMID: 38459538 Free PMC article.
-
Obesity Epidemic: Is Its Impact on Total Joint Arthroplasty Underestimated? An Analysis of National Trends.Clin Orthop Relat Res. 2017 Jul;475(7):1798-1806. doi: 10.1007/s11999-016-5222-4. Clin Orthop Relat Res. 2017. PMID: 28054327 Free PMC article.
-
CORR Insights(®): short-term complications have more effect on cost-effectiveness of THA than implant longevity.Clin Orthop Relat Res. 2015 May;473(5):1709-11. doi: 10.1007/s11999-015-4185-1. Epub 2015 Feb 10. Clin Orthop Relat Res. 2015. PMID: 25666147 Free PMC article. No abstract available.
References
-
- Khatod M, Inacio M, Paxton EW, et al. Knee replacement: epidemiology, outcomes, and trends in Southern California: 17,080 replacements from 1995 through 2004. Acta Orthop. 2008 Dec;79(6):812–819. - PubMed
-
- Katz JN, Phillips CB, Baron JA, et al. Association of hospital and surgeon volume of total hip replacement with functional status and satisfaction three years following surgery. Arthritis & Rheumatism. 2003 Feb;48(2):560–568. [see comment] - PubMed
-
- Lohmander LS, Engesaeter LB, Herberts P, Ingvarsson T, Lucht U, Puolakka TJ. Standardized incidence rates of total hip replacement for primary hip osteoarthritis in the 5 Nordic countries: similarities and differences. Acta Orthop. 2006 Oct;77(5):733–740. - PubMed
-
- Centers for Disease Control and Prevention. U.S. Centers for Disease Control; 2009. Health, United States, 2009.